[2]
Forel JM,Roch A,Marin V,Michelet P,Demory D,Blache JL,Perrin G,Gainnier M,Bongrand P,Papazian L, Neuromuscular blocking agents decrease inflammatory response in patients presenting with acute respiratory distress syndrome. Critical care medicine. 2006 Nov; [PubMed PMID: 16932229]
[3]
Alhazzani W,Alshahrani M,Jaeschke R,Forel JM,Papazian L,Sevransky J,Meade MO, Neuromuscular blocking agents in acute respiratory distress syndrome: a systematic review and meta-analysis of randomized controlled trials. Critical care (London, England). 2013 Mar 11; [PubMed PMID: 23497608]
[4]
Wastila WB,Maehr RB,Turner GL,Hill DA,Savarese JJ, Comparative pharmacology of cisatracurium (51W89), atracurium, and five isomers in cats. Anesthesiology. 1996 Jul; [PubMed PMID: 8694363]
[5]
Cammu G,Coddens J,Hendrickx J,Deloof T, Dose requirements of infusions of cisatracurium or rocuronium during hypothermic cardiopulmonary bypass. British journal of anaesthesia. 2000 May; [PubMed PMID: 10844834]
[6]
Prielipp RC,Coursin DB,Scuderi PE,Bowton DL,Ford SR,Cardenas VJ Jr,Vender J,Howard D,Casale EJ,Murray MJ, Comparison of the infusion requirements and recovery profiles of vecuronium and cisatracurium 51W89 in intensive care unit patients. Anesthesia and analgesia. 1995 Jul; [PubMed PMID: 7598277]
[7]
Pühringer FK,Heier T,Dodgson M,Erkola O,Goonetilleke P,Hofmockel R,Gaetke MR,Mortensen CR,Upadhyaya B,Eriksson LI, Double-blind comparison of the variability in spontaneous recovery of cisatracurium- and vecuronium-induced neuromuscular block in adult and elderly patients. Acta anaesthesiologica Scandinavica. 2002 Apr; [PubMed PMID: 11952434]
[8]
Arain SR,Kern S,Ficke DJ,Ebert TJ, Variability of duration of action of neuromuscular-blocking drugs in elderly patients. Acta anaesthesiologica Scandinavica. 2005 Mar; [PubMed PMID: 15752394]
[9]
Bluestein LS,Stinson LW Jr,Lennon RL,Quessy SN,Wilson RM, Evaluation of cisatracurium, a new neuromuscular blocking agent, for tracheal intubation. Canadian journal of anaesthesia = Journal canadien d'anesthesie. 1996 Sep; [PubMed PMID: 8874910]
[10]
Konstadt SN,Reich DL,Stanley TE 3rd,DePerio M,Chuey C,Schwartzbach C,Abou-Donia M, A two-center comparison of the cardiovascular effects of cisatracurium (Nimbex) and vecuronium in patients with coronary artery disease. Anesthesia and analgesia. 1995 Nov; [PubMed PMID: 7486039]
[11]
Butterly A,Bittner EA,George E,Sandberg WS,Eikermann M,Schmidt U, Postoperative residual curarization from intermediate-acting neuromuscular blocking agents delays recovery room discharge. British journal of anaesthesia. 2010 Sep; [PubMed PMID: 20576632]
[13]
Murphy GS,Szokol JW,Avram MJ,Greenberg SB,Marymont JH,Vender JS,Gray J,Landry E,Gupta DK, Intraoperative acceleromyography monitoring reduces symptoms of muscle weakness and improves quality of recovery in the early postoperative period. Anesthesiology. 2011 Nov; [PubMed PMID: 21946094]